Fusion event
HBV-MPZL2 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
AAGATTGCAATTGATTATGCCTGCCAGGTTTTATCCAAAGGTTACCAAATATTTACCATTGGATAAGGGTATTAAACCTTATTATCCAGAACATCTAGTT| |AATCATTACTTCCAAACTAGACACTATTTACACACTCTATGGAAGGCGGGTATATTATATAAGAGAGAAACAACACATAGCGCCTCATTTTGTGGGTCAC
End
118125981/118255266 (Hg38)
Nearest miRNA
hsa-mir-10392/Upstream/4805178; hsa-let-7a-2/Downstream/388734;
Upstream sequence
CAAAGAAAAGTTTCCATTAACTTCAAGAAATACTAGGGTTCTTGTTCTTGGAAATCATCTCAGCTTCCTAAAACACAAAACAAAAGTTTAAATGGATAAT
Downstream sequence
ATATTTGAGAAGAGTACAATAGGAATACTTGGCATTATGAATTACATATATGTTATTAGAAGGAAAATATTCTGAGGGAAAGTATTCATATTCTCCCCCA
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.